Evidence map›Paper›PMID 34833980›Full record

ArticleMolecules (Basel, Switzerland)2021

Anti-Hyperglycemic Effects of Refined Fractions from

Zheling Feng, Zhujun Fang, Cheng Chen, Chi Teng Vong, Jiali Chen, Ruohan Lou, Maggie Pui Man Hoi, Lishe Gan, Ligen Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Sweet triterpenoid glycoside fromCurrent research in food science · 2024
    Article
  4. Natural Products: Therapeutic Properties and Beyond II.Molecules (Basel, Switzerland) · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zheling FengState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Zhujun FangDepartment of Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China.
Cheng ChenState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Chi Teng VongState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Jiali ChenState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Ruohan LouState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Maggie Pui Man HoiState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Lishe GanSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
Ligen LinState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.ORCID 0000-0002-6799-5327
University of Macau · MOWuyi University · CNZhejiang University · CN

Funding

National Natural Science Foundation of China 82073715, 22077111, 81872756Research Fund of University of Macau MYRG2018-00037-ICMS, MYRG2020-00091-ICMSThe Science and Technology Development Fund, Macau SAR FDCT 0031/2019/A1
6 · The paper itself

Abstract

To identify the chemical components responsible for the anti-hyperglycemic effect of

Indexed as

AnimalsCell LineDiabetes Mellitus, ExperimentalHypoglycemic AgentsJuglandaceaeMaleMiceMice, Inbred C57BLPlant ExtractsPlant LeavesStreptozocinHypoglycemic AgentsPlant ExtractsStreptozocinanti-hyperglycemiaCyclocarya paliurusflavonoidspolysaccharidestriterpenoids

Identifiers

PMID34833980
PMCPMC8620367
OpenAlexW3211827558

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.